Presentation Information

[LS-39-2]How Satralizumab changed treatment strategy in NMOSD- Real World Evidence from Japan -

Kazuo Fujihara (Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine/Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan)